Alicia McElhaney

Articles From This Author
Neurocrine Biosciences Leads Pre-Market Biotech Movers
Apr 12, 2017 9:32 AM EDT
Mylan Falls on FDA Warning on Quality Control
Apr 11, 2017 12:26 PM EDT
Biotech Movers Trading Positive Ahead of Market's Open
Apr 11, 2017 9:30 AM EDT
Medivation Founder Takes Helm at Axovant, Shares Spike
Apr 10, 2017 10:00 AM EDT
Endo international, AngioDynamics Lead Biotech Movers
Apr 7, 2017 9:25 AM EDT
Valeant Shares Close Below $10 for First Time Since 2008
Apr 5, 2017 4:03 PM EDT
Ackman Reflects on His Valeant Investment
Mar 30, 2017 8:30 PM EDT
Mylan Hires Former SEC Commissioner for Chief Legal Officer Position
Mar 28, 2017 3:35 PM EDT
Former Valeant CEO Files Suit Against the Company
Mar 28, 2017 9:12 AM EDT
Impax Gains 38% On CEO Appointment, Talk of Sale
Mar 27, 2017 2:30 PM EDT
Mylan Hit After Abbott Dumps Shares
Mar 24, 2017 11:41 AM EDT
Here's How to Invest in Hospital Stocks Ahead of AHCA Vote
Mar 24, 2017 10:27 AM EDT
A Deal is Imminent For Depomed, CFO Says
Mar 23, 2017 7:07 PM EDT
Valeant CEO Compensation Revealed, Shares Climb
Mar 23, 2017 10:49 AM EDT
Can Abbott Outperform Despite Alere?
Mar 22, 2017 2:47 PM EDT
Regenxbio Leads Biotech Movers Ahead of Market's Open
Mar 22, 2017 9:31 AM EDT
Mylan's Government Connections Go Deeper Than Initially Believed
Mar 21, 2017 9:06 AM EDT
CytomX Soars on Bristol-Myers Partnership
Mar 20, 2017 9:21 AM EDT
Valeant Shares Skyrocket After Hours on ValueAct Buy
Mar 16, 2017 5:05 PM EDT
Health Care Investors Attempt to Parse Trump Budget
Mar 16, 2017 10:25 AM EDT
Incyte Pops on Continued Gilead Takeout Speculation
Mar 10, 2017 4:30 PM EST
Here's Why Weight Watchers' New CEO Should Be a Woman
Mar 8, 2017 2:39 PM EST
Kite Completes Additional Public Offering
Mar 2, 2017 2:00 PM EST
Valeant Shares Plummet After Reporting 13% Drop In Sales
Feb 28, 2017 4:13 PM EST
Biotech Movers: Cempra flys high on phase three results
Feb 24, 2017 9:38 AM EST